MaxCyte Inc (NASDAQ: MXCT) is -45.11% lower on its value in year-to-date trading and has touched a low of $2.00 and a high of $5.20 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MXCT stock was last observed hovering at around $2.23 in the last trading session, with the day’s gains setting it 916.16%.
Currently trading at $918.39K, the stock is 3.06% and -4.45% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.93 million and changing 933626% at the moment leaves the stock -33.14% off its SMA200. MXCT registered -44.71% loss for a year compared to 6-month loss of -45.75%. The firm has a 50-day simple moving average (SMA 50) of $2.4072 and a 200-day simple moving average (SMA200) of $3.439775.
The stock witnessed a -3.36% gain in the last 1 month and extending the period to 3 months gives it a -17.27%, and is 9.00% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.85% over the week and 6.27% over the month.
MaxCyte Inc (MXCT) has around 114 employees, a market worth around $244.53M and $37.68M in sales. Profit margin for the company is -110.92%. Distance from 52-week low is 15.00% and -55.77% from its 52-week high. The company has generated returns on investments over the last 12 months (-19.26%).
with sales reaching $9.57M over the same period.The EPS is expected to grow by 8.54% this year, but quarterly earnings will post 6.85% year-over-year. Quarterly sales are estimated to shrink -8.25% in year-over-year returns.
166.0 institutions hold shares in MaxCyte Inc (MXCT), with institutional investors hold 76.90% of the company’s shares. The shares outstanding are 106.31M, and float is at 97.94M with Short Float at 3.64%. Institutions hold 75.79% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 8.14 million shares valued at $31.92 million. The investor’s holdings represent 7.7814 of the MXCT Shares outstanding. As of 2024-06-30, the second largest holder is CADIAN CAPITAL MANAGEMENT, LP with 7.62 million shares valued at $29.88 million to account for 7.285 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 5.65 million shares representing 5.3948 and valued at over $22.13 million, while MILLENNIUM MANAGEMENT LLC holds 4.9484 of the shares totaling 5.18 million with a market value of $20.3 million.
MaxCyte Inc (MXCT) Insider Activity
MaxCyte Inc disclosed in a document filed with the SEC on Mar 18 ’25 that Soleymannezhad Ali (Chief Commercial Officer) sold a total of 1,211 shares of the company’s common stock. The trade occurred on Mar 18 ’25 and was made at $3.18 per share for $3850.0. Following the transaction, the insider now directly holds 59439.0 shares of the MXCT stock.
Still, SEC filings show that on Mar 18 ’25, Sandoval David I. (GENERAL COUNSEL) disposed off 353 shares at an average price of $3.18 for $1122.0. The insider now directly holds 64,219 shares of MaxCyte Inc (MXCT).
